Φορτώνει......
An antigen-encapsulating nanoparticle platform for T(H)1/17 immune tolerance therapy
Tolerogenic nanoparticles (NPs) are rapidly being developed as specific immunotherapies to treat autoimmune disease. However, many NP-based therapies conjugate antigen (Ag) directly to the NP posing safety concerns due to antibody binding or require the co-delivery of immunosuppressants to induce to...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Nanomedicine |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5237397/ https://ncbi.nlm.nih.gov/pubmed/27720992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.09.007 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|